Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin

Debbie Ann Shirley, Ina Stephens

Research output: Contribution to journalArticle

Abstract

Incomplete Kawasaki disease was diagnosed in a 3-year-old boy. Because intravenous immune globulin infusion was not tolerated, he was treated with infliximab and methylprednisolone. Coronary aneurysms were not visualized on initial or follow-up echocardiograms. To our knowledge, this is the first report to document the use of infliximab and methylprednisolone as first line therapy for Kawasaki disease.

Original languageEnglish (US)
Pages (from-to)978-979
Number of pages2
JournalPediatric Infectious Disease Journal
Volume29
Issue number10
DOIs
StatePublished - Oct 2010

Keywords

  • Kawasaki
  • infliximab
  • initial

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin'. Together they form a unique fingerprint.

  • Cite this